Ignite Creation Date:
2025-12-24 @ 5:01 PM
Ignite Modification Date:
2026-02-20 @ 6:46 PM
Study NCT ID:
NCT02092350
Status:
COMPLETED
Last Update Posted:
2018-09-24
First Post:
2014-03-17
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Efficacy of Grazoprevir (MK-5172) + Elbasvir (MK-8742) in Participants With Chronic Hepatitis C and Chronic Kidney Disease (MK-5172-052)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-03-17
Start Date Type:
ACTUAL
Primary Completion Date:
2015-03-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-09-02
Completion Date Type:
ACTUAL
First Submit Date:
2014-03-17
First Submit QC Date:
None
Study First Post Date:
2014-03-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-02-03
Results First Submit QC Date:
None
Results First Post Date:
2016-04-12
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-08-23
Last Update Post Date:
2018-09-24
Last Update Post Date Type:
ACTUAL